<?xml version="1.0" encoding="UTF-8"?>
<p>The conventional bronchodilators used in asthma include Î²2 agonist, anticholinergics and PDE inhibitors are well known for their cardiac stimulation which is a serious side effect (
 <xref rid="B52" ref-type="bibr">Undem, 2006</xref>). However, it is possible that the presence of combination of Ca
 <sup>++</sup> channel blockers with anticholinergics and PDE inhibitory like agents, as determined in the essential oil of 
 <italic>T. serrulatus,</italic> are likely to offset the cardiac stimulation usually associated with these bronchodilators, particularly when given orally.
</p>
